Neonc Technologies Holdings Inc (NTHI)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$3.20+0.95%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · NTHI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenues | — | 0.0 | 0.1 | — |
| Total Revenues | — | 0.0 | 0.1 | — |
| Operating Expenses & Income | ||||
| R&D Expenses | 6.5 | 3.6 | 3.0 | — |
| Operating Income | (40.7) | (58.2) | (7.1) | — |
| Earnings from Continuing Operations | ||||
| Interest Expense | 2.6 | 2.5 | 2.6 | — |
| Net Income | ||||
| Net Income | (43.0) | (62.1) | (11.9) | — |
| Per Share | ||||
| Basic EPS | (1.67) | (3.20) | (0.69) | — |
| Diluted EPS | (1.67) | (3.20) | (0.69) | — |
| Basic Weighted Avg Shares | 25.8 | 19.4 | 17.3 | — |
| Diluted Weighted Avg Shares | 25.8 | 19.4 | 17.3 | — |
| Supplemental | ||||
| EBIT | (40.7) | (58.2) | (7.1) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.